These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19884379)

  • 1. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem.
    Queenan AM; Shang W; Flamm R; Bush K
    Antimicrob Agents Chemother; 2010 Jan; 54(1):565-9. PubMed ID: 19884379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative review of the carbapenems.
    Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
    Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
    Yang Y; Bhachech N; Bush K
    J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.
    Mushtaq S; Ge Y; Livermore DM
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1313-9. PubMed ID: 15047535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
    Hilliard JJ; Melton JL; Hall L; Abbanat D; Fernandez J; Ward CK; Bunting RA; Barron A; Lynch AS; Flamm RK
    Antimicrob Agents Chemother; 2011 Feb; 55(2):836-44. PubMed ID: 21135187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.
    Walsh F; Bracher S; Turner P; Amyes S
    Chemotherapy; 2007; 53(6):407-9. PubMed ID: 17934261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
    Gimeno C; Cantón R; García A; Gobernado M;
    Rev Esp Quimioter; 2010 Sep; 23(3):144-52. PubMed ID: 20844845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.
    Babini GS; Yuan M; Livermore DM
    Antimicrob Agents Chemother; 1998 May; 42(5):1168-75. PubMed ID: 9593145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
    Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    Marti S; Sánchez-Céspedes J; Alba V; Vila J
    Int J Antimicrob Agents; 2009 Feb; 33(2):181-2. PubMed ID: 18977642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre.
    van der Bij AK; Mol M; van Westreenen M; Goessens WH; Pitout JD
    Scand J Infect Dis; 2011 Aug; 43(8):596-602. PubMed ID: 21506891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1beta-methylcarbapenem, against transferable IMP-1 metallo-beta-lactamase producers.
    Nagano R; Adachi Y; Hashizume T; Morishima H
    J Antimicrob Chemother; 2000 Mar; 45(3):271-6. PubMed ID: 10702544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
    J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot D; Chanal C
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():219-23. PubMed ID: 2808209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenems in the USA: focus on doripenem.
    Lister PD
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):793-809. PubMed ID: 17914914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.